| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |